SCHEMBL25683366

SCHEMBL25683366

CCCc1cccc2oc3ccc4c5ccccc5n(C)c4c3c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALKBH5 Q6P6C2 1/20 0.44
▸ FTO Q9C0B1 1/20 0.44
▸ GPR3 P46089 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.37
▸ IDO1 P14902 1/20 0.37
▸ KDM4E B2RXH2 5/20 0.37
▸ MAPT P10636 3/20 0.37
▸ NPEPPS P55786 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ TSHR P16473 3/20 0.35
▸ HTT P42858 3/20 0.35
▸ LMNA P02545 3/20 0.35
▸ RAB9A P51151 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ASAH1 Q13510 1/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ LIMK1 P53667 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25682172 0.94 ALKBH5 (0.41) ALKBH5FTOGPR3HSP90AA1IDO1
SCHEMBL25682955 0.87 ALKBH5 (0.36) ALKBH5FTOGPR3KDM4EMAPT
SCHEMBL25682993 0.86 ALKBH5 (0.43) ALKBH5FTOGPR3HSP90AA1IDO1
SCHEMBL25683036 0.86 ALKBH5 (0.43) ALKBH5FTOGPR3HSP90AA1IDO1
SCHEMBL25682952 0.83 SMN1; SMN2 (0.35) ALKBH5FTOKDM4EMAPTALDH1A1
SCHEMBL25683145 0.83 NPEPPS (0.40) GPR3KDM4EMAPTNPEPPSALDH1A1
SCHEMBL25682129 0.80 SMN1; SMN2 (0.36) KDM4EALDH1A1TSHRHTTLMNA
SCHEMBL13183680 0.80 ALKBH5 (0.50) ALKBH5FTOGPR3HSP90AA1IDO1
SCHEMBL25683143 0.79 GPR3 (0.39) ALKBH5GPR3KDM4EMAPTNPEPPS
SCHEMBL25683284 0.78 ALKBH5 (0.46) ALKBH5FTOGPR3HSP90AA1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed
EP-4190791-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT Kyulux, Inc. (JP) 2023-06-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CCNE2, CRY2 ALKBH5 2658/4885FTO 1081/4885GPR3 1535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback